• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?

作者信息

Piltin Mara A, Boughey Judy C

机构信息

Department of Surgery, Mayo Clinic, Rochester, MN, USA.

出版信息

Ann Surg Oncol. 2020 Dec;27(Suppl 3):707-708. doi: 10.1245/s10434-020-08954-0. Epub 2020 Jul 31.

DOI:10.1245/s10434-020-08954-0
PMID:32737696
Abstract
摘要

相似文献

1
ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?ASO作者反思：新辅助化疗后对淋巴结阳性乳腺癌进行前哨淋巴结手术：从肿瘤学角度看是否安全？
Ann Surg Oncol. 2020 Dec;27(Suppl 3):707-708. doi: 10.1245/s10434-020-08954-0. Epub 2020 Jul 31.
2
ASO Author Reflections: Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients Can Stop After Removal of Three Lymph Nodes.ASO作者反思：临床淋巴结阴性患者新辅助化疗后前哨淋巴结切除在切除三个淋巴结后可停止。
Ann Surg Oncol. 2020 Dec;27(Suppl 3):848-849. doi: 10.1245/s10434-020-08874-z. Epub 2020 Jul 21.
3
ASO Author Reflections: Low Rates of Axillary Recurrence in Clinically Node-Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Alone Following Pathologic Response to Neoadjuvant Chemotherapy.ASO作者反思：新辅助化疗病理反应后仅接受前哨淋巴结活检的临床淋巴结阳性乳腺癌患者腋窝复发率低
Ann Surg Oncol. 2021 May;28(5):2630-2631. doi: 10.1245/s10434-020-09259-y. Epub 2020 Oct 29.
4
ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery.《美国外科医师学会（ASO）作者反思：乳腺癌手术中前哨淋巴结阳性》
Ann Surg Oncol. 2022 Feb;29(2):1096-1097. doi: 10.1245/s10434-021-10836-y. Epub 2021 Sep 24.
5
ASO Author Reflections: A Perspective on Nonsentinel Axillary Lymph Node Status in Sentinel Lymph Node-Positive Early Breast Cancer After Primary Systemic Therapy and ALND-Predict.ASO作者反思：原发性全身治疗和腋窝淋巴结清扫预测后前哨淋巴结阳性早期乳腺癌中非前哨腋窝淋巴结状态的观点
Ann Surg Oncol. 2023 Sep;30(9):5705-5706. doi: 10.1245/s10434-023-13297-7. Epub 2023 Feb 23.
6
ASO Author Reflections: Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer.美国骨科学会作者反思：避免腋窝淋巴结清扫术：新辅助化疗对隐匿性原发性乳腺癌的益处。
Ann Surg Oncol. 2020 Dec;27(Suppl 3):865-866. doi: 10.1245/s10434-020-08939-z. Epub 2020 Jul 28.
7
ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone.ASO作者反思：完善仅适合前哨淋巴结活检的淋巴结阳性乳腺癌患者的风险评估
Ann Surg Oncol. 2020 Oct;27(10):3593-3594. doi: 10.1245/s10434-020-08634-z. Epub 2020 May 21.
8
ASO Author Reflections: MicroRNA-Based Nomogram for Prediction of Sentinel Lymph Node Metastasis in ER+/HER2- Breast Cancer in Hoping for a Possible Omission of Sentinel Lymph Node Biopsy.ASO作者反思：基于微小RNA的列线图预测雌激素受体阳性/人表皮生长因子受体2阴性乳腺癌前哨淋巴结转移，以期可能省略前哨淋巴结活检
Ann Surg Oncol. 2020 Dec;27(Suppl 3):810-811. doi: 10.1245/s10434-020-08797-9. Epub 2020 Jul 6.
9
[Sentinel lymph node biopsy and neoadjuvant treatment in breast cancer].[乳腺癌前哨淋巴结活检与新辅助治疗]
Bull Cancer. 2017 Oct;104(10):892-901. doi: 10.1016/j.bulcan.2017.08.003. Epub 2017 Sep 8.
10
ASO Author Reflections: Standardizing Pathology Examination of Sentinel Lymph Nodes in Invasive Lobular Carcinoma: Less Is More.ASO作者反思：规范浸润性小叶癌前哨淋巴结的病理检查：少即是多。
Ann Surg Oncol. 2022 Oct;29(10):6466-6467. doi: 10.1245/s10434-022-12330-5. Epub 2022 Aug 5.

引用本文的文献

1
Superparamagnetic Iron Oxide for Identifying Sentinel Lymph Node in Breast Cancer after Neoadjuvant Chemotherapy: Feasibility Study.超顺磁性氧化铁用于新辅助化疗后乳腺癌前哨淋巴结的识别：可行性研究
J Clin Med. 2021 Jul 16;10(14):3149. doi: 10.3390/jcm10143149.